Cargando…

Myeloid Sarcoma Presenting as Obstructive Jaundice

Myeloid sarcoma (MS) is a rare solid neoplasm that consists of extramedullary myeloid precursor cells. Generally, it is associated with underlying acute myeloid leukemia (AML) or AML yet to manifest clinically. It can present as isolated, also known as primary MS without evidence of AML or other mye...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, Matthew, Wu, Yue, Niazi, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436724/
https://www.ncbi.nlm.nih.gov/pubmed/34594168
http://dx.doi.org/10.1159/000514528
_version_ 1783752037312233472
author Patterson, Matthew
Wu, Yue
Niazi, Mina
author_facet Patterson, Matthew
Wu, Yue
Niazi, Mina
author_sort Patterson, Matthew
collection PubMed
description Myeloid sarcoma (MS) is a rare solid neoplasm that consists of extramedullary myeloid precursor cells. Generally, it is associated with underlying acute myeloid leukemia (AML) or AML yet to manifest clinically. It can present as isolated, also known as primary MS without evidence of AML or other myeloproliferative neoplasms. We present the case of a previously healthy 36-year-old male, who was admitted to hospital with new-onset painful obstructive jaundice and final diagnosis of isolated MS was made after through investigations. We are pleased to report that he had favorable response to the treatment and remains well.
format Online
Article
Text
id pubmed-8436724
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-84367242021-09-29 Myeloid Sarcoma Presenting as Obstructive Jaundice Patterson, Matthew Wu, Yue Niazi, Mina Case Rep Gastroenterol Single Case Myeloid sarcoma (MS) is a rare solid neoplasm that consists of extramedullary myeloid precursor cells. Generally, it is associated with underlying acute myeloid leukemia (AML) or AML yet to manifest clinically. It can present as isolated, also known as primary MS without evidence of AML or other myeloproliferative neoplasms. We present the case of a previously healthy 36-year-old male, who was admitted to hospital with new-onset painful obstructive jaundice and final diagnosis of isolated MS was made after through investigations. We are pleased to report that he had favorable response to the treatment and remains well. S. Karger AG 2021-08-02 /pmc/articles/PMC8436724/ /pubmed/34594168 http://dx.doi.org/10.1159/000514528 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Patterson, Matthew
Wu, Yue
Niazi, Mina
Myeloid Sarcoma Presenting as Obstructive Jaundice
title Myeloid Sarcoma Presenting as Obstructive Jaundice
title_full Myeloid Sarcoma Presenting as Obstructive Jaundice
title_fullStr Myeloid Sarcoma Presenting as Obstructive Jaundice
title_full_unstemmed Myeloid Sarcoma Presenting as Obstructive Jaundice
title_short Myeloid Sarcoma Presenting as Obstructive Jaundice
title_sort myeloid sarcoma presenting as obstructive jaundice
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436724/
https://www.ncbi.nlm.nih.gov/pubmed/34594168
http://dx.doi.org/10.1159/000514528
work_keys_str_mv AT pattersonmatthew myeloidsarcomapresentingasobstructivejaundice
AT wuyue myeloidsarcomapresentingasobstructivejaundice
AT niazimina myeloidsarcomapresentingasobstructivejaundice